NASDAQ$ADUS
Addus HomeCare Corporation · Q1 2021 earnings
Q1 2021 earnings · · Investor relations
Briefing
Addus HomeCare's first quarter results for 2021 were announced, demonstrating revenue growth and increased net income.
Addus HomeCare Corporation reported a 7.9% increase in net service revenues, reaching $205.3 million for the first quarter of 2021. Net income increased to $8.9 million, or $0.55 per diluted share. Adjusted EBITDA increased 8.9% to $19.3 million.
- Net service revenues increased by 7.9% to $205.3 million compared to Q1 2020.
- Net income rose to $8.9 million, with earnings per diluted share at $0.55.
- Adjusted earnings per diluted share were reported at $0.74.
- Adjusted EBITDA increased by 8.9% to $19.3 million.
Headline financials
Revenue & EPS history
Addus · Revenue · Quarterly
$205M
Revenue by segment
Addus · $205M total across 3 segments · Q1 2021
- Personal Care$165M—80.3%
- Hospice$36.1M—17.6%
- Home Health$4.34M—2.1%
Forward guidance
Addus HomeCare anticipates the COVID-19 pandemic will continue to steadily decrease in severity over the next several quarters. They expect to benefit from the statewide Illinois rate increase that became effective April 1, 2021.
Tailwinds
- Improving organic growth trends ahead of pre-pandemic levels in both personal care and home health.
- Accelerating growth in vaccinations across the country and increasing facility access.
- Expect a return to higher volume trends in hospice business.
- Well positioned to meet expected demand in all operating segments as overall conditions improve and more restrictions are lifted.
- Integration of acquired transactions is largely complete, with positive growth seen since acquisition.
Headwinds
- Impacted by both the pandemic and the historic winter storm that interrupted business throughout many significant markets.
- COVID-19 challenges
- Uncertainty regarding the outcome of discussions with managed care organizations
- Changes in reimbursement, changes in government regulations
- Increased competition for Addus HomeCare’s services
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q1 2021
+1.2%
Avg return
Earnings day
+2.3%
Avg return
5 days after
+5.0%
Avg return
30 days after
58%
37 / 64 earnings
Positive
+23.7%
Q4 2019
Best reaction
-19.6%
Q4 2013
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -1.7% | -0.6% | -10.6% | |
| Q4 2025 | -9.1% | -12.0% | -17.0% | |
| Q3 2025 | -5.9% | -5.0% | -4.1% | |
| Q1 2025 | +4.1% | +6.3% | +7.5% | |
| Q4 2024 | -10.4% | -12.0% | -10.1% | |
| Q3 2024 | -1.7% | +1.0% | -2.1% | |
| Q2 2024 | +3.5% | +3.6% | +8.5% | |
| Q1 2024 | +6.5% | +11.3% | +16.8% | |
| Q4 2023 | +3.4% | +5.3% | +16.4% | |
| Q3 2023 | -3.7% | +3.3% | +7.0% | |
| Q2 2023 | +1.2% | +3.9% | -0.1% | |
| Q1 2023 | +5.8% | +0.3% | +10.3% | |
| Q4 2022 | +3.9% | +2.5% | -0.4% | |
| Q3 2022 | +3.1% | +3.8% | +4.8% | |
| Q2 2022 | +3.1% | +0.6% | -3.9% | |
| Q1 2022 | -2.3% | -4.7% | -4.2% | |
| Q4 2021 | +20.5% | +20.4% | +15.8% | |
| Q3 2021 | -0.5% | +9.1% | -8.9% | |
| Q2 2021 | +9.1% | +5.3% | +4.0% | |
| Q1 2021 | -6.6% | -8.1% | -10.0% | |
| Q4 2020 | -11.3% | -14.2% | -11.3% | |
| Q3 2020 | +11.9% | +10.3% | +4.6% | |
| Q2 2020 | +2.7% | -4.6% | -7.1% | |
| Q1 2020 | +10.2% | +2.7% | +22.5% | |
| Q4 2019 | +23.7% | +8.5% | +42.1% | |
| Q3 2019 | -0.9% | -0.1% | +8.6% | |
| Q2 2019 | +1.4% | +4.4% | -0.2% | |
| Q1 2019 | +3.6% | +3.0% | +8.8% | |
| Q4 2018 | -2.8% | -7.8% | -3.8% | |
| Q3 2018 | +6.5% | +10.8% | +16.7% | |
| Q2 2018 | -4.4% | -7.1% | -3.4% | |
| Q1 2018 | +3.1% | +1.8% | +11.9% | |
| Q4 2017 | -0.3% | +8.6% | +38.5% | |
| Q3 2017 | -1.4% | -5.8% | -7.8% | |
| Q2 2017 | -0.3% | -1.4% | -1.3% | |
| Q1 2017 | +11.3% | +9.4% | +2.6% | |
| Q4 2016 | +1.2% | +0.1% | -7.5% | |
| Q3 2016 | +17.4% | +28.7% | +32.7% | |
| Q2 2016 | +13.8% | +8.6% | +27.1% | |
| Q1 2016 | -1.1% | — | — | |
| Q4 2015 | -16.6% | — | — | |
| Q3 2015 | -12.7% | — | — | |
| Q2 2015 | +4.4% | — | — | |
| Q1 2015 | -3.4% | — | — | |
| Q4 2014 | +3.7% | — | — | |
| Q3 2014 | +7.1% | — | — | |
| Q2 2014 | +1.3% | — | — | |
| Q1 2014 | +1.8% | — | — | |
| Q4 2013 | -19.6% | — | — | |
| Q3 2013 | +4.3% | — | — | |
| Q2 2013 | +9.3% | — | — | |
| Q1 2013 | +0.9% | — | — | |
| Q4 2012 | +13.2% | — | — | |
| Q3 2012 | +10.5% | — | — | |
| Q2 2012 | +1.1% | — | — | |
| Q1 2011 | -0.0% | — | — | |
| Q1 2012 | -7.8% | — | — | |
| Q4 2011 | +6.6% | — | — | |
| Q3 2010 | -1.3% | — | — | |
| Q3 2011 | -1.3% | — | — | |
| Q2 2011 | -17.3% | — | — | |
| Q2 2010 | -17.3% | — | — | |
| Q4 2010 | +0.2% | — | — | |
| Q1 2010 | +2.6% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro